Sfoglia per Autore
New Insights in Physical Therapy and Rehabilitation in Axial Spondyloarthritis: A Review
2019-01-01 Perrotta, Fabio Massimo; Musto, Antonio; Lubrano, Ennio
Effectiveness of adalimumab for the treatment of psoriatic arthritis: An Italian real-life retrospective study
2019-01-01 D'Angelo, S.; Cantini, F.; Ramonda, R.; Cantarini, L.; Carletto, A.; Chimenti, M. S.; Sedie, A. D.; Foti, R.; Gerli, R.; Lomater, C.; Lubrano, E.; Marchesoni, A.; Zabotti, A.; Salvarani, C.; Scrivo, R.; Scarpa, R.; Tramontano, G.; Nannini, C.; Lorenzin, M.; Fabbroni, M.; Martinis, F.; Perricone, R.; Carli, L.; Visalli, E.; Rovera, G.; Perrotta, F. M.; Quartuccio, L.; Altobelli, A.; Costa, L.; Niccoli, L.; Ortolan, A.; Caso, F.
Assessment of bone morphogenic protein 2 and interleukine-17A in patients with axial spondyloarthritis and their potential role in the new bone formation: a cross-sectional study
2019-01-01 Perrotta, Fabio Massimo; Scriffignano, Silvia; Lubrano, Ennio
Role of comorbidities in spondyloarthritis including psoriatic arthritis
2019-01-01 Scriffignano, Silvia; Perrotta, Fabio Massimo; De Socio, Antonia; Lubrano, Ennio
Analysis of potential determinants for a treat-to-target strategy in psoriatic arthritis patients from a real-world setting
2019-01-01 Lubrano, Ennio; Scriffignano, Silvia; De Socio, Antonia; Perrotta, Fabio Massimo
An Assessment of Hand Erosive Osteoarthritis: Correlation of Radiographic Severity with Clinical, Functional and Laboratory Findings
2019-01-01 Perrotta, Fabio Massimo; Scriffignano, Silvia; De Socio, Antonia; Lubrano, Ennio
Residual disease activity and associated factors in Psoriatic Arthritis
2019-01-01 Lubrano, Ennio; Scriffignano, Silvia; Perrotta, Fabio Massimo
Psoriatic arthritis, psoriatic disease, or psoriatic syndrome?
2019-01-01 Lubrano, E.; Scriffignano, S.; Perrotta, F. M.
Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients
2019-01-01 Lubrano, Ennio; Perrotta, Fabio Massimo; Scriffignano, Silvia; Coates, Laura C; Helliwell, Philip
TNF-alpha inhibitors for the six treatment targets of psoriatic arthritis
2019-01-01 Lubrano, E.; Scriffignano, S.; Perrotta, F. M.
Occult axial involvement in patients with psoriatic arthritis mutilans: a case report
2019-01-01 Perrotta, F M; Scriffignano, S; De Socio, A; Lubrano, E
Spondiloartriti assiali: dalla patogenesi della neoformazione ossea alla valutazione di possibili biomarcatori di attività di malattia e remissione clinica
2019-03-06 Perrotta, Fabio Massimo
Dr. Lubrano, et al reply
2020-01-01 Lubrano, E.; Scriffignano, S.; Perrotta, F. M.
Improvement of Function and Its Determinants in a Group of Axial Spondyloarthritis Patients Treated with TNF Inhibitors: A Real-Life Study
2020-01-01 Lubrano, Ennio; Perrotta, Fabio Massimo; Manara, Maria; D'Angelo, Salvatore; Ramonda, Roberta; Punzi, Leonardo; Addimanda, Olga; Salvarani, Carlo; Marchesoni, Antonio
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment
2020-01-01 Navarini, Luca; Caso, Francesco; Costa, Luisa; Currado, Damiano; Stola, Liliana; Perrotta, Fabio; Delfino, Lorenzo; Sperti, Michela; Deriu, Marco A; Ruscitti, Piero; Pavlych, Viktoriya; Corrado, Addolorata; Di Benedetto, Giacomo; Tasso, Marco; Ciccozzi, Massimo; Laudisio, Alice; Lunardi, Claudio; Cantatore, Francesco Paolo; Lubrano, Ennio; Giacomelli, Roberto; Scarpa, Raffaele; Afeltra, Antonella
Multimorbidity and comorbidity in psoriatic arthritis–a perspective
2020-01-01 Lubrano, E.; Scriffignano, S.; Perrotta, F. M.
Impact of Comorbidities on Disease Activity, Patient Global Assessment, and Function in Psoriatic Arthritis: A Cross-Sectional Study
2020-01-01 Lubrano, Ennio; Scriffignano, Silvia; Azuaga, Ana Belen; Ramirez, Julio; Cañete, Juan D; Perrotta, Fabio Massimo
Remission, low disease activity and improvement of pain and function in psoriatic arthritis patients treated with IL-12/23 and IL-17 inhibitors. A multicenter prospective study
2020-01-01 Perrotta, F M; Delle Sedie, A; Scriffignano, S; Volpe, P; Cordisco, E; Milano, N; Gabini, M; Lubrano, E
Rheumatology Care in the Face of COVID-19
2020-01-01 Lubrano, Ennio; Scriffignano, Silvia; Perrotta, Fabio Massimo
Assessment of the Patient Acceptable Symptom State (PASS) in psoriatic arthritis: Association with disease activity and quality of life indices
2020-01-01 Lubrano, E.; Scriffignano, S.; Azuaga, A. B.; Ramirez, J.; Canete, J.; Perrotta, F. M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| New Insights in Physical Therapy and Rehabilitation in Axial Spondyloarthritis: A Review | 1-gen-2019 | Perrotta, Fabio Massimo; Musto, Antonio; Lubrano, Ennio | |
| Effectiveness of adalimumab for the treatment of psoriatic arthritis: An Italian real-life retrospective study | 1-gen-2019 | D'Angelo, S.; Cantini, F.; Ramonda, R.; Cantarini, L.; Carletto, A.; Chimenti, M. S.; Sedie, A. D.; Foti, R.; Gerli, R.; Lomater, C.; Lubrano, E.; Marchesoni, A.; Zabotti, A.; Salvarani, C.; Scrivo, R.; Scarpa, R.; Tramontano, G.; Nannini, C.; Lorenzin, M.; Fabbroni, M.; Martinis, F.; Perricone, R.; Carli, L.; Visalli, E.; Rovera, G.; Perrotta, F. M.; Quartuccio, L.; Altobelli, A.; Costa, L.; Niccoli, L.; Ortolan, A.; Caso, F. | |
| Assessment of bone morphogenic protein 2 and interleukine-17A in patients with axial spondyloarthritis and their potential role in the new bone formation: a cross-sectional study | 1-gen-2019 | Perrotta, Fabio Massimo; Scriffignano, Silvia; Lubrano, Ennio | |
| Role of comorbidities in spondyloarthritis including psoriatic arthritis | 1-gen-2019 | Scriffignano, Silvia; Perrotta, Fabio Massimo; De Socio, Antonia; Lubrano, Ennio | |
| Analysis of potential determinants for a treat-to-target strategy in psoriatic arthritis patients from a real-world setting | 1-gen-2019 | Lubrano, Ennio; Scriffignano, Silvia; De Socio, Antonia; Perrotta, Fabio Massimo | |
| An Assessment of Hand Erosive Osteoarthritis: Correlation of Radiographic Severity with Clinical, Functional and Laboratory Findings | 1-gen-2019 | Perrotta, Fabio Massimo; Scriffignano, Silvia; De Socio, Antonia; Lubrano, Ennio | |
| Residual disease activity and associated factors in Psoriatic Arthritis | 1-gen-2019 | Lubrano, Ennio; Scriffignano, Silvia; Perrotta, Fabio Massimo | |
| Psoriatic arthritis, psoriatic disease, or psoriatic syndrome? | 1-gen-2019 | Lubrano, E.; Scriffignano, S.; Perrotta, F. M. | |
| Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients | 1-gen-2019 | Lubrano, Ennio; Perrotta, Fabio Massimo; Scriffignano, Silvia; Coates, Laura C; Helliwell, Philip | |
| TNF-alpha inhibitors for the six treatment targets of psoriatic arthritis | 1-gen-2019 | Lubrano, E.; Scriffignano, S.; Perrotta, F. M. | |
| Occult axial involvement in patients with psoriatic arthritis mutilans: a case report | 1-gen-2019 | Perrotta, F M; Scriffignano, S; De Socio, A; Lubrano, E | |
| Spondiloartriti assiali: dalla patogenesi della neoformazione ossea alla valutazione di possibili biomarcatori di attività di malattia e remissione clinica | 6-mar-2019 | Perrotta, Fabio Massimo | |
| Dr. Lubrano, et al reply | 1-gen-2020 | Lubrano, E.; Scriffignano, S.; Perrotta, F. M. | |
| Improvement of Function and Its Determinants in a Group of Axial Spondyloarthritis Patients Treated with TNF Inhibitors: A Real-Life Study | 1-gen-2020 | Lubrano, Ennio; Perrotta, Fabio Massimo; Manara, Maria; D'Angelo, Salvatore; Ramonda, Roberta; Punzi, Leonardo; Addimanda, Olga; Salvarani, Carlo; Marchesoni, Antonio | |
| Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment | 1-gen-2020 | Navarini, Luca; Caso, Francesco; Costa, Luisa; Currado, Damiano; Stola, Liliana; Perrotta, Fabio; Delfino, Lorenzo; Sperti, Michela; Deriu, Marco A; Ruscitti, Piero; Pavlych, Viktoriya; Corrado, Addolorata; Di Benedetto, Giacomo; Tasso, Marco; Ciccozzi, Massimo; Laudisio, Alice; Lunardi, Claudio; Cantatore, Francesco Paolo; Lubrano, Ennio; Giacomelli, Roberto; Scarpa, Raffaele; Afeltra, Antonella | |
| Multimorbidity and comorbidity in psoriatic arthritis–a perspective | 1-gen-2020 | Lubrano, E.; Scriffignano, S.; Perrotta, F. M. | |
| Impact of Comorbidities on Disease Activity, Patient Global Assessment, and Function in Psoriatic Arthritis: A Cross-Sectional Study | 1-gen-2020 | Lubrano, Ennio; Scriffignano, Silvia; Azuaga, Ana Belen; Ramirez, Julio; Cañete, Juan D; Perrotta, Fabio Massimo | |
| Remission, low disease activity and improvement of pain and function in psoriatic arthritis patients treated with IL-12/23 and IL-17 inhibitors. A multicenter prospective study | 1-gen-2020 | Perrotta, F M; Delle Sedie, A; Scriffignano, S; Volpe, P; Cordisco, E; Milano, N; Gabini, M; Lubrano, E | |
| Rheumatology Care in the Face of COVID-19 | 1-gen-2020 | Lubrano, Ennio; Scriffignano, Silvia; Perrotta, Fabio Massimo | |
| Assessment of the Patient Acceptable Symptom State (PASS) in psoriatic arthritis: Association with disease activity and quality of life indices | 1-gen-2020 | Lubrano, E.; Scriffignano, S.; Azuaga, A. B.; Ramirez, J.; Canete, J.; Perrotta, F. M. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile